Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease

European Journal of Pediatrics

Volumn 168, Issue 2, 2009, Pages 181-185

  Okada, Keiko ^a   Hara, Junichi ^a   Maki, Ichiro ^b   Miki, Kazunori ^c   Matsuzaki, Kouji ^d   Matsuoka, Taro ^e   Yamamoto, Takehisa ^f   Nishigaki, Toshinori ^g   Kurotobi, Syunji ^h   Sano, Tetsuya ⁱ  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b Ikeda Municipal Hospital   (Japan)

^c Itami Municipal Hospital   (Japan)

^d Suita Municipal Hospital   (Japan)

^e TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^f Mino City Hospital   (Japan)

^g Osaka Keisatsu Hospital   (Japan)

^h OSAKA UNIVERSITY   (Japan)

ⁱ OSAKA KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

Coronary disease; Kawasaki disease; Methylprednisolone

Indexed keywords

ACETYLSALICYLIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CORTICOSTEROID; HEPARIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

AMINOTRANSFERASE BLOOD LEVEL; ARTERY LESION; ARTICLE; BRADYCARDIA; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; HYPOTHERMIA; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ASPARTATE AMINOTRANSFERASES; BILIRUBIN; C-REACTIVE PROTEIN; CHILD, PRESCHOOL; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-GLOBULINS; HEPARIN; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PULSE THERAPY, DRUG; RISK FACTORS; TREATMENT OUTCOME;

EID: 58149095186     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-008-0727-9     Document Type: Article

References (12)

1. YF Cheung TC Yung SC Tam MH Ho AK Chau 2004 Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis J Am Coll Cardiol 43 120 124
2. RC Dale MA Saleem S Daw MJ Dillon 2000 Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin J Pediatr 137 723 726
3. R Dhillon P Clarkson AE Donald AJ Powe M Nash V Novelli MJ Dillon JE Deanfield 1996 Endothelial dysfunction late after Kawasaki disease Circulation 94 2103 2106
4. K Durongpisitkul J Soongswang D Laohaprasitiporn A Nana C Prachuabmoh C Kangkagate 2003 Immunoglobulin failure and retreatment in Kawasaki disease Pediatr Cardiol 24 145 148
5. K Furusho T Kamiya H Nakano N Kiyosawa K Shinomiya T Hayashidera T Tamura O Hirose Y Manabe T Yokoyama M Kawarano K Baba C Mori 1984 High-dose intravenous gammaglobulin for Kawasaki disease Lancet 2 1055 1058
6. Y Inoue Y Okada M Shinohara T Kobayashi T Kobayashi T Tomomasa K Takeuchi A Morikawa 2006 A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome J Pediatr 149 336 341
7. T Jibiki M Terai T Kurosaki H Nakajima K Suzuki H Inomata I Terashima T Honda K Yasukawa H Hamada Y Kohno 2004 Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease Eur J Pediatr 163 229 233
8. JW Newburger M Takahashi MA Gerber MH Gewitz LY Tani JC Burns ST Shulman AF Bolger P Ferrieri RS Baltimore WR Wilson LM Baddour ME Levison TJ Pallasch DA Falace KA Taubert Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease Council on Cardiovascular Disease in the Young American Heart Association 2004 Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Pediatrics 114 1708 1733
9. JW Newburger LA Sleeper BW McCrindle LL Minich W Gersony VL Vetter AM Atz JS Li M Takahashi AL Baker SD Colan PD Mitchell GL Klein RP Sundel Pediatric Heart Network Investigators 2007 Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease N Engl J Med 15 663 675
10. T Sano S Kurotobi K Matsuzaki T Yamamoto I Maki K Miki S Kogaki J Hara 2007 Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment Eur J Pediatr 166 131 137
11. CA Wallace JW French SJ Kahn DD Sherry 2000 Initial intravenous gammaglobulin treatment failure in Kawasaki disease Pediatrics 105 E78
12. DA Wright JW Newburger A Baker RP Sundel 1996 Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids J Pediatr 128 146 149